Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Clinical trial NCT07243899 · COMPLETED
Trial details
- NCT number
- NCT07243899
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-01
- Primary completion
- 2025-02-28
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.